NCT00946829View on ClinicalTrials.gov

Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure Rise

CompletedOBSERVATIONAL
Enrollment

18,299

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

May 31, 2007

Conditions
Hypertension
Interventions
DRUG

telmisartan

Trial Locations (12)

Unknown

Boehringer Ingelheim Investigational Site, Boehringer Ingelheim Investigational Site

Boehringer Ingelheim Investigational Site, Boehringer Ingelheim Investigational Site

Boehringer Ingelheim Investigational Site, Boehringer Ingelheim Investigational Site

Boehringer Ingelheim Investigational Site, Boehringer Ingelheim Investigational Site

Boehringer Ingelheim Investigational Site, Boehringer Ingelheim Investigational Site

Boehringer Ingelheim Investigational Site, Boehringer Ingelheim Investigational Site

Boehringer Ingelheim Investigational Site, Boehringer Ingelheim Investigational Site

Boehringer Ingelheim Investigational Site, Boehringer Ingelheim Investigational Site

Boehringer Ingelheim Investigational Site, Boehringer Ingelheim Investigational Site

Boehringer Ingelheim Investigational Site, Boehringer Ingelheim Investigational Site

Boehringer Ingelheim Investigational Site, Boehringer Ingelheim Investigational Site

Boehringer Ingelheim Investigational Site, Boehringer Ingelheim Investigational Site

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00946829 - Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure Rise | Biotech Hunter | Biotech Hunter